Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cancer Drugs Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of cancer across the globe and surge in global geriatric population
5.1.1.2. Increase in government expenditures on healthcare
5.1.1.3. Elevated development of biosimilar in oncology arena
5.1.2. Restraints
5.1.2.1. High cost and lack of availability of the drug
5.1.3. Opportunities
5.1.3.1. Increase in number of pipeline drugs
5.1.3.2. Growing R&D for development of effient cancer drugs
5.1.4. Challenges
5.1.4.1. Adverse effects associated with the use of cancer drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Cancer Drugs Market, by Type
6.1. Introduction
6.2. Bladder Cancer
6.3. Blood Cancer
6.4. Breast Cancer
6.5. Gastrointestinal Cancer
6.6. Liver Cancer
6.7. Lung and Bronchus Cancer
6.8. Skin Cancer

7. Cancer Drugs Market, by Application
7.1. Introduction
7.2. Chemotherapy
7.3. Hormone Therapy
7.4. Immunotherapy
7.5. Targeted Therapy

8. Americas Cancer Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Cancer Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Cancer Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. Amgen Inc.
12.1.3. Astellas Pharma Inc.
12.1.4. AstraZeneca PLC
12.1.5. Bayer AG
12.1.6. Bristol-Myers Squibb Company
12.1.7. Eli Lilly and Company
12.1.8. Gilead Sciences, Inc.
12.1.9. GSK PLC
12.1.10. Johnson & Johnson
12.1.11. Merck & Co., Inc.
12.1.12. Novartis AG
12.1.13. Pfizer Inc.
12.1.14. Sanofi SA
12.1.15. Takeda Pharmaceutical Company Limited
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. CANCER DRUGS MARKET RESEARCH PROCESS
FIGURE 2. CANCER DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. CANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CANCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CANCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CANCER DRUGS MARKET DYNAMICS
FIGURE 7. CANCER DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. CANCER DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CANCER DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. CANCER DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CANCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES CANCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. CANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. CANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. CANCER DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. CANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANCER DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. CANCER DRUGS MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CANCER DRUGS MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CANCER DRUGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CANCER DRUGS MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CANCER DRUGS MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CANCER DRUGS MARKET SIZE, BY LUNG AND BRONCHUS CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CANCER DRUGS MARKET SIZE, BY SKIN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. CANCER DRUGS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CANCER DRUGS MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CANCER DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CANCER DRUGS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. CANADA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. CANADA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. MEXICO CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. MEXICO CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES CANCER DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. ASIA-PACIFIC CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. ASIA-PACIFIC CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC CANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. AUSTRALIA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. AUSTRALIA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. CHINA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. CHINA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. INDIA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. INDIA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. INDONESIA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. INDONESIA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. JAPAN CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. JAPAN CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. MALAYSIA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. MALAYSIA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. PHILIPPINES CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. PHILIPPINES CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. SINGAPORE CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. SINGAPORE CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. SOUTH KOREA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. SOUTH KOREA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. TAIWAN CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. TAIWAN CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. THAILAND CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. THAILAND CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. VIETNAM CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. VIETNAM CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA CANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. DENMARK CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. DENMARK CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. EGYPT CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. EGYPT CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. FINLAND CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. FINLAND CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. FRANCE CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. FRANCE CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. GERMANY CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. GERMANY CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ISRAEL CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. ISRAEL CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ITALY CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. ITALY CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. NETHERLANDS CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. NETHERLANDS CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. NIGERIA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. NIGERIA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. NORWAY CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. NORWAY CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. POLAND CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. POLAND CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. QATAR CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. QATAR CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. RUSSIA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. RUSSIA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SAUDI ARABIA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SAUDI ARABIA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SOUTH AFRICA CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH AFRICA CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SPAIN CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. SPAIN CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. SWEDEN CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. SWEDEN CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. SWITZERLAND CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. SWITZERLAND CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. TURKEY CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. TURKEY CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED ARAB EMIRATES CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. CANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 105. CANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 106. CANCER DRUGS MARKET LICENSE & PRICING